Prophylactic repair of renal artery stenosis is not justified in patients who require infrarenal aortic reconstruction  by Williamson, W.Kent et al.
14
Management of asymptomatic renal artery steno-
sis (ARAS) that is incidentally discovered on an aor-
togram before aortic vascular repair remains contro-
versial. Some studies have reported increased mor-
bidity rates associated with prophylactic renal artery
revascularization in patients who undergo infrarenal
aortic reconstruction, whereas others have not.1,2
Serial studies with duplex ultrasound have indicated a
40% progression rate of renal artery stenosis at 2
years.3 Tollefson et al.4 used serial renal angiography
to document progression of renal artery stenosis in
50% of patients over 4.5 years with a 15% incidence
of renal artery occlusion. Functional progression of
ARAS in terms of hypertension and progressive renal
failure is less well documented. This is especially
important in patients who require infrarenal aortic
reconstruction, in whom prophylactic repair of ARAS
is often considered. The purpose of this study was to
evaluate the functional outcome of ARAS that is
detected on a routine preoperative aortogram in
patients who require reconstruction of the infrarenal
aorta for occlusive or aneurysmal disease.
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Purpose: Simultaneous prophylactic repair of asymptomatic renal artery stenosis (ARAS)
in patients who require infrarenal aortoiliac reconstruction is controversial. This study
documents the natural history of ARAS in patients who require aortic reconstruction.
Methods: Two hundred patients who required aortic reconstruction from 1985 to 1990
for indications other than hypertension or renal salvage were identified. ARAS was not
repaired. Preoperative angiograms were available for 171 of 200 patients and were
reviewed for renal artery stenosis. Patients were assessed for atherosclerotic risk factors,
survival, preoperative and follow-up blood pressure, serum creatinine level, antihyper-
tensive medication usage, and need for dialysis.
Results: The mean duration of follow-up was 6.3 years. Twenty-four of 171 patients
(14%) had preoperative unilateral 70% to 99% diameter reduction ARAS, and eight (5%)
had bilateral 70% to 99% ARAS. Clinical features associated with ³70% ARAS included
coronary artery disease, increased age, and a diagnosis of hypertension (p < 0.05).
Patients with ³70% ARAS did not have a decreased 7-year survival rate (66% vs 84%; 
p = 0.10) but had higher systolic blood pressures (153 ± 25 vs 138 ± 30 mm Hg; p <
0.05) as well as increased numbers of antihypertensive medications at follow-up (1.1 ±
0.2 vs 0.7 ± 1; p < 0.05). The mean serum creatinine level (1.1 ± 0.3 preoperative vs 1.4
± 0.8 mg/dl; p = NS) was not increased. One patient (0.58%) with polycystic kidney dis-
ease and minimal renal artery stenosis required dialysis.
Conclusions: High-grade ARAS in patients who are undergoing infrarenal aortic recon-
struction is associated at late follow-up with increased systolic blood pressure and a need
for increased numbers of antihypertensive medications, but not decreased survival rate,
dialysis dependence, or an increase in serum creatinine level. These data do not support
renal artery repair in patients with ARAS who undergo infrarenal aortic reconstruction.
(J Vasc Surg 1998;28:14-22.)
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PATIENTS AND METHODS
Patients. Two hundred consecutive patients
from the operative logs and vascular registry of the
Portland Veterans Affairs (VA) Hospital who
required infrarenal aortic reconstruction between
1985 and 1990 and whose records did not docu-
ment an indication for renal artery reconstruction
(suspected renovascular hypertension or renal insuf-
ficiency) were identified. Patients in whom renovas-
cular disease was clinically suspected and who were
treated for renal artery stenosis were excluded. Of
the remaining patients, 171 had preoperative aor-
tograms that were available for evaluation of renal
artery stenosis. None of the 171 patients had renal
artery stenosis treated at the Portland VA Hospital
during the follow-up period. Charts were reviewed,
and the patients’ age, sex, type of operation, and
indication for operation were recorded. Data were
collected concerning preoperative blood pressure,
antihypertensive medications, diabetes, creatinine
level, tobacco use, coronary artery disease (history
of angina or congestive heart failure or electrocar-
diographic evidence of previous myocardial infarc-
tion), angiographically demonstrated lower extremi-
ty arterial occlusive disease, and cerebrovascular dis-
ease (history of stroke or transient ischemic attacks).
Follow-up was by chart review. Follow-up data were
obtained on survival, serial systolic and diastolic
blood pressures, creatinine level, the number and
type of antihypertensive medications, and whether
the patient had a need for renal dialysis.
Angiograms were reviewed separately, with the
reviewer blinded to all preoperative and follow-up
data. The degree of stenosis of each main and/or
duplicated renal artery was recorded. Renal artery
stenosis was measured with calipers comparing the
width of the contrast column at the site of greatest
luminal narrowing with the width of the contrast
column in the distal renal artery at a site not obvi-
ously involved with poststenotic dilatation. Small
accessory renal arteries were not considered.
Patients were grouped according to maximum
renal artery stenosis present in any artery (0%, group
A; 1% to 29%, group B; 30% to 69%, group C; 70%
to 99%, group D [unilateral and bilateral]; and
occluded, group E). Groups A and D plus E were
compared for changes in preoperative and follow-up
blood pressure, antihypertensive medications, and
creatinine level.
Statistical analysis. Multiple regression analysis
was used to compare preoperative and postoperative
variables in patients with varying degrees of ARAS.
Survival analysis was performed using multivariate
proportional hazards fit model. All statistical tests were
performed with the statistics software package JMP
(1995, SAS Institute, Cary, N.C.). Statistical services
were provided through the General Clinical Research
Center at Oregon Health Sciences University.
Table I, B. Indications for aortic reconstruction
No. of patients %
Abdominal aortic aneurysm 68 40
Aortoiliac occlusive disease 93 54
Visceral ischemia 2 1
Pseudoaneurysm 2 1
Inflammatory aneurysm 3 2
Other* 3 2
*Includes infected graft.
Table I, A. Demographic features of 171 patients
who required infrarenal aortic reconstruction
No. of patients %
Male 169 99
Female 2 1
Hypertension 87 51
Diabetes 19 11
Renal insufficiency 1 0.6
Preoperative dialysis 0 0.0
Coronary disease 83 49
Peripheral vascular disease 72 42
Cerebrovascular disease 37 22
Tobacco 165 96
Fig. 1. Kaplan-Meier survival curve. Group A, no renal
artery stenosis; group B, 1% to 29% stenosis; group C, 30%
to 69% stenosis; group D + E, ³70% stenosis. There was no
significant difference between groups. Age and comor-
bidities are not addressed in this survival curve (see text
and Table IX).
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RESULTS
The mean duration of follow-up was 6.3 years
(range, 1.0 to 10.6 years; median, 6.4 years) for the
171 patients enrolled in the study. Ninety-nine per-
cent of the patients were male, and the mean age at
aortography was 63 years. Preoperative demograph-
ic data are listed in Table I, A, and indications for
operation in Table I, B. The maximum percent
diameter reduction of a main or duplicated renal
artery in the 171 patients is listed in Table II.
Twenty-four patients had unilateral and eight
patients bilateral 70% to 99% renal artery stenosis.
The three patients with 100% renal artery stenosis
had contralateral renal artery stenosis in the range of
50% to 70%. Survival data by group are demonstrat-
ed in a Kaplan-Meier curve in Fig. 1.
Table III lists the reconstructive procedures per-
formed. One hundred twenty-seven of the proce-
dures involved direct aortic reconstruction, and 37
were extraanatomic bypass grafting procedures.
Other indications for operation include repair of
pseudoaneurysms and removal of previously placed
infected prosthetic grafts. The operative mortality
rate was 1.2%; death was a result of myocardial
infarction in both perioperative deaths.
Multiple regression analysis of the clinical fea-
tures evaluated in this study indicated that coronary
artery disease, a preoperative diagnosis of hyperten-
sion, and age were significantly associated with
increased levels of renal artery stenosis at the time of
aortography (Table IV). One-way analysis of vari-
ance between groups at the time of presentation
indicated that groups did not vary in terms of dias-
tolic blood pressure (DBP), creatinine level, and the
number of antihypertensive medications taken
(DBP, p = 0.566; creatinine level, p = 0.417; num-
bers of antihypertensives; p = 0.131). Systolic blood
pressure, however, was different between groups at
presentation (p = 0.024; Tables V to VIII). There
was no difference in patients’ clinical variables
between groups in terms of whether the indication
for operation was aortoiliac occlusive disease or
aneurysm. In addition, the distribution of renal
artery stenosis in patients who underwent operation
for aortoiliac occlusive disease or aneurysm did not
differ.
At last follow-up, patients with ³70% ARAS on
their preoperative angiograms had higher systolic
blood pressures (153.3 ± 25.2 mm Hg vs  148 ± 23
mm Hg; p = 0.0236) and used slightly more antihy-
pertensive medications (1.54 ± 1.24 vs 1.14 ± 0.18;
p = 0.0280) but had no increase in serum creatinine
level (1.4 ± 0.8 vs 1.1 ± 0.3 mg/dl; p = 0.1821) or
significant change in DBP (Tables V to VIII). One-
way analysis of variance between groups at last fol-
low-up showed no significant difference in creati-
nine level and DBP (creatinine level, p = 0.6881;
DBP, p = 0.2424). However, systolic blood pressure
and numbers of antihypertensive medications were
different between groups (systolic blood pressure, 
p = 0.0428; antihypertensive medications, p =
0.0353; Tables V to VIII).
One of 171 patients followed-up became dialy-
sis-dependent. That patient had polycystic kidney
disease and minimal renal artery stenosis. None of
the eight patients with bilateral 70% to 99% stenoses
became dialysis dependent or had a worsening crea-
tinine level or increased use of antihypertensive
medications beyond the statistical means noted
above.
Proportional hazards fit model identified dia-
betes and lower extremity arterial occlusive disease
as clinical conditions that adversely influence the
survival rate when adjusting for age and other clin-
ical conditions. Increased renal artery stenosis was
not associated with a decreased survival rate when
other clinical features and age were considered
(Table IX).
Table III. Reconstructive procedures in 171
patients with infrarenal aortoiliac aneurysmal or
occlusive disease
Procedure No. %
Aortic tube graft 18 11
Aortobiiliac graft 48 28
Axillary bifemoral bypass 7 4
Aortobifemoral bypass 55 32
Iliofemoral bypass 2 1
Femorofemoral bypass 27 16
Axillary unifemoral bypass 3 2
Aortoiliac endarterectomy 4 2
Other 7 4
Table II. Distribution of renal artery stenosis in
the most severely narrowed renal artery in 171
patients who required infrarenal aortic reconstruc-
tion
Renal artery stenosis No. %
0% (group A) 77 45
1% to 29% (group B) 22 13
30% to 69% (group C) 37 22
70% to 99% (group D)
Unilateral 24 14
Bilateral 8 5
Occluded (group E) 3 2
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DISCUSSION
One of the most debated issues regarding renal
artery stenosis is how to address asymptomatic renal
artery stenosis (ARAS) that is detected on a routine
preoperative aortogram for patients who are under-
going aortic reconstruction. Management of ARAS
is based on many factors, such as the anatomic nat-
ural history of renal artery stenosis, technical con-
siderations that surround surgery, and ultimately,
the clinical outcome as a result of renal artery steno-
sis progression with regards to renal insufficiency
and hypertension. Some authors suggest that many
“asymptomatic” lesions are actually mildly sympto-
matic and may contribute to the presence of hyper-
tension. Indeed, we cannot exclude a renovascular
component to the hypertension in our patients who
had hypertension and renal artery stenosis; however,
none were suspected of having renal artery stenosis
before angiography, and other authors contend that
even if a lesion is mildly symptomatic, given the
attendant increased morbidity rate in those patients
with significant comorbidities, repair should not be
Table IV. Association of renal artery stenosis present on preoperative angiogram with clinical features in
171 patients who required infrarenal aortic reconstruction
Mean renal artery stenosis Mean renal artery stenosis 
Clinical feature No. with condition with condition (%) without condition (%) p*
Age 171 — — 0.0378
Hypertension 87 36.7 21.4 0.0385
Diabetes 20 16.7 30.8 0.1776
Coronary disease 84 37.7 20.9 0.0167
Peripheral vascular disease 72 32.6 26.7 0.2510
Cerebrovascular disease 37 38.6 26.7 0.3759
*By multiple regression analysis, adjusting for age, hypertension, diabetes, coronary artery disease, peripheral vascular disease, and cere-
brovascular disease.
Table V. Systolic blood pressure before operation versus that at last follow-up in 171 patients who
required infrarenal aortic reconstruction (mean follow-up, 6.3 years)
Maximum renal artery Mean SBP before Mean SBP at last Change in
stenosis in any renal artery operation (mm Hg) follow-up (mm Hg) SBP (mm Hg)
0% 135.3 ± 22.13 137.7 ± 30.0 2.40 ± 3.66
1% to 29% 140.3 ± 16.5 138.0 ± 22.6 –2.31 ± 6.83
30% to 69% 141.4 ± 18.7 140.7 ± 26.6 –0.67 ± 5.27
70% to 99% 148.4 ± 22.9 153.3 ± 25.2 4.91 ± 5.42
SBP, Systolic blood pressure.
Data shown are mean ± standard deviation.
By multiple regression, p is 0.0236 for increased SBP over time and with increasing stenosis, considering clinical features of age, hyper-
tension, coronary artery disease, cerebrovascular disease, diabetes, and peripheral vascular disease. See text for one-way analysis of vari-
ance between groups at preoperative time, last follow-up, and for change in SBP.
Table VI. DBP before operation versus that at last follow-up in 171 patients who required infrarenal aor-
tic reconstruction (mean follow-up, 6.3 years)
Maximum renal artery Mean DBP before Mean DBP at last Change in
stenosis in any renal artery operation (mm Hg) follow-up (mm Hg) DBP (mm Hg)
Normal 75.90 ± 11.65 73.57 ± 14.74 –2.32 ± 17.06
1% to 29% 78.77 ± 9.63 71.18 ± 11.27 –7.59 ± 15.36
30% to 69% 78.51 ± 10.21 70.03 ± 17.50 –8.49 ± 7.20
70% to 99% 78.06 ± 13.71 76.83 ± 14.04 –1.22 ± 18.25
Data shown are mean ± standard deviation.
By multiple regression, p is 0.3149 for increased DBP over time and with increasing stenosis, considering clinical features of age, hyper-
tension, coronary artery disease, cerebrovascular disease, diabetes, and peripheral vascular disease. See text for one-way analysis of vari-
ance between groups at preoperative time, last follow-up, and for change in DBP.
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undertaken unless the patient has specific indications
for renal artery bypass.1,5,6
Cambria et al.1 argue that patients with few
comorbidities have equal morbidity and mortality
rates when comparing aortic reconstruction alone
with aortic reconstruction and renal artery repair.
Cambria et al. refer specifically to patients with sig-
nificant aortic disease and low cardiac morbidity.
However, very few patients who require aortic
reconstruction are likely to have low cardiac risk.1 As
many as 90% of patients who require abdominal aor-
tic aneurysm repair have significant coronary artery
disease as documented on coronary angiography;
cardiac mortality rates range from 2% to 5% and
morbidity rates range up to 11%.7-9 One report
quotes mortality figures for combined aortic and
renal construction at 5% to 31%.10 In addition, the
majority opinion is clearly that in a typical patient
who requires aortic reconstruction the addition of
simultaneous renal artery repair results in overall
increased perioperative morbidity rates.11-15 Given
that the majority of patients are likely to have signif-
icant comorbidities that at least somewhat increase
operative risk for simultaneous renal artery repair,
one must carefully evaluate the merits of combining
aortic reconstruction with renal artery repair for
asymptomatic or perhaps minimally symptomatic
renal artery stenosis.
Zierler et al.3 have provided some of the most
specific information concerning the progression of
anatomic renal artery stenosis detected by duplex
ultrasound in patients who were evaluated for hyper-
tension, decreased renal function, or both. Although
such patients are not directly comparable with those
described in this report, the results indicate that
renal artery stenosis in such patients is often pro-
gressive. Seventy-six patients were followed-up for a
mean of 32 months, and the cumulative incidence of
Table VIII. Creatinine level before operation versus that at last follow-up in 171 patients who required
infrarenal aortic reconstruction (mean follow-up, 6.3 years)
Maximum renal artery Mean creatinine level Mean creatinine level Change in creatinine
stenosis in any renal artery before operation (mg/dl) at last follow-up (mg/dl) level (mg/dl)
0% 1.06 ± 0.26 1.26 ± 0.91 0.20 ± 0.83
1% to 29% 1.14 ± 0.23 1.19 ± 0.43 0.05 ± 0.37
30% to 69% 1.14 ± 0.31 1.40 ± 0.75 0.26 ± 0.72
70% to 99% 1.11 ± 0.29 1.39 ± 0.82 0.27 ± 0.64
Data shown are mean ± standard deviation.
By multiple regression, p is 0.1821 for increased creatinine level over time and with increasing stenosis, considering clinical features of
age, hypertension, coronary artery disease, cerebrovascular disease, diabetes, and peripheral vascular disease. See text for one-way analy-
sis of variance between groups at preoperative time, last follow-up, and for change in creatinine level.
Table IX. Proportional hazards fit model to iden-
tify clinical features that predict survival in 171
patients who underwent infrarenal aortic recon-
struction
Clinical feature Prob > c2
Age 0.0035
Hypertension 0.6279
Diabetes 0.0205
Coronary disease 0.3195
Peripheral vascular disease 0.0508
Cerebrovascular disease 0.5961
Percent renal artery stenosis 0.1354
Table VII. Number of antihypertensive agents before operation versus that at last follow-up in 171
patients who required infrarenal aortic reconstruction (mean follow-up, 6.3 years)
Maximum renal artery Mean no. Mean no. at
stenosis in any renal artery before operation last follow-up Change in no.
0% 0.68 ± 0.12 0.92 ± 1.04 0.23 ± 1.14
1% to 29% 0.59 ± 0.23 1.36 ± 1.09 0.77 ± 1.02
30% to 69% 0.89 ± 0.17 1.19 ± 1.02 0.29 ± 0.91
70% to 99% 1.14 ± 0.18 1.54 ± 1.24 0.40 ± 1.31
Data shown are mean ± standard deviation.
By multiple regression, p is 0.0280 for increased use of antihypertensive medications over time and with increasing stenosis, considering
clinical features of age, hypertension, coronary artery disease, cerebrovascular disease, diabetes, and peripheral vascular disease. See text for
one-way analysis of variance between groups at preoperative time, last follow-up, and for change in use of antihypertensive medications.
progression from normal to ³60% renal artery steno-
sis was 0% at 1 year, 0% at 2 years, and 8% at 3 years,
whereas progression of a ³60% renal artery stenosis
was 30% at 1 year, 44% at 2 years, and 48% at 3 years.
Seven percent of renal arteries with ³60% stenosis
progressed to occlusion. Progression occurred at a
rate of 7% per year for all patients.3
Tollefson and Ernst4 also performed a retrospec-
tive analysis of 48 patients who were found to have
renal artery stenosis on preoperative aortograms for
aortic reconstruction. They evaluated follow-up aor-
tograms to assess progression of renal artery stenosis
and found a rate of progression of 4.6% per year,
regardless of the initial degree of stenosis, and an
overall renal artery occlusion incidence of 9% in
patients with ³60% stenosis initially. From this, the
authors concluded that “preocclusive” renal artery
stenosis (³60%) should undergo “prophylactic”
repair at the time of aortic reconstruction.4
However, because of the retrospective nature of this
study, it is likely that these patients had indications
for repeat aortography other than simply follow-up
assessment of renal artery stenosis. Atherosclerotic
disease in these patients may therefore be more pro-
gressive than in the general population of patients
who require aortic reconstruction. In addition,
Tollefson and Ernst noted changes in creatinine level
and blood pressure did not correlate with stenosis
progression.
Instead of following stenosis progression, our
study focused on evaluating the clinical outcome in
patients with untreated renal artery stenosis in
whom renal artery disease was not suspected at pre-
sentation. It is our supposition that the central issue
driving the decision to revascularize ARAS is
whether stenosis leads to clinically significant future
decline, that is, dialysis dependence, uncontrollable
hypertension, or severe renal insufficiency. Whereas
patients with high-grade renal artery stenosis may
lose renal mass over time, this may not be of clinical
significance in certain patient groups. It should be
clearly demonstrated that ARAS leads to future
uncontrollable hypertension, renal insufficiency, or
dialysis dependence before repairing asymptomatic
renal artery stenosis.
Our findings of a greater than 20% incidence of
³70% renal artery stenosis in patients who undergo
aortography before aortic reconstruction is consis-
tent with other reports, as is the distribution of pre-
existing comorbidities.4 The distribution of proce-
dures for our study group is also consistent with
other reports; however, our patient population is
strongly skewed to the male sex, reflecting the VA
cohort.4 Statistical analysis using multiple regres-
sion, accounting for age, increased blood pressure,
diabetes, coronary artery disease, lower extremity
arterial occlusive disease, and cerebrovascular disease
identified age, increased blood pressure, and coro-
nary artery disease as being predictive for severity of
renal artery stenosis. Other authors have remarked
that multiple retrospective analyses have varied in
identifying clinical features that predict stenosis, and
most suggest that there is no reliable feature to pre-
dict stenosis.2-6,16
In long-term follow-up of blood pressure, crea-
tinine level, and use of antihypertensive medications,
we found by multiple regression analysis that took
into account age, hypertension, diabetes, percent
renal artery stenosis, lower extremity arterial occlu-
sive disease, cerebrovascular disease, and coronary
artery disease, that there is a significant increase in
systolic blood pressure and the numbers of antihy-
pertensive medications used in patients with ³70%
renal artery stenosis when compared with those who
have no evidence of stenosis. It is important to note,
however, that because the survival rate in this study
was not affected by the presence of increased ARAS,
the increase in systolic blood pressure and use of
antihypertensive medications, albeit statistically sig-
nificant (153 mm Hg vs 137 mm Hg, and 1.54 anti-
hypertensives vs 0.92) likely does not have practical
clinical significance in patients who require aortic
reconstruction. Would the added risk of performing
a combined renal artery revascularization and aortic
reconstruction be worth reducing an already reason-
ably controlled systolic blood pressure? In addition,
DBP and creatinine level did not change significant-
ly during follow-up. Although patients with renal
artery stenosis may lose renal mass without a change
in creatinine level, the fact remains that only one
patient in the study went on to require dialysis, and
that patient had polycystic kidney disease with mini-
mal renal artery stenosis.
It is important that the results of this study not
be inappropriately extrapolated to other clinical set-
tings. For instance, we have not addressed the issue
of repair of symptomatic renal artery stenosis in con-
junction with aortic reconstruction or repair of
asymptomatic renal artery stenosis in the setting of
suprarenal aortic surgery. The data presented here
also do not imply that patients with ARAS will never
have a deterioration in renal function, only that
severe renal compromise must be quite rare in
patients with ARAS who require aortic reconstruc-
tion who are observed for a median of 6.4 years. In
addition, the small number of patients in this study
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Dr. R. Eugene Zierler (Seattle, Wash.). Although the
indications for renal revascularization in the setting of
established renovascular hypertension generally are
accepted, the role of intervention for renal artery stenosis
in patients with controlled hypertension or mild degrees
of renal insufficiency is not clearly established. This creates
a therapeutic dilemma whenever renal artery lesions are
discovered incidentally in patients who are evaluated for
arterial disease elsewhere. Such situations are likely to arise
frequently because the prevalence of significant renal
artery stenoses in patients with abdominal aortic
aneurysms or lower-extremity arterial occlusive disease is
in the range of 30% to 40%. In the absence of a random-
ized clinical trial that compares early renal revasculariza-
tion with medical therapy alone, clinical decisions must be
on the basis of what is known about the natural history of
renal artery stenosis. The critical issue is whether a high-
grade but “asymptomatic” renal artery stenosis is likely to
be associated over time with adverse consequences that
could be avoided by early intervention.
This paper from the group at Oregon Health Sciences
University sheds some light on this important issue. The
authors conducted a retrospective review of 171 patients
who underwent surgical procedures for abdominal aortic
disease and had no compelling indications for renal revas-
cularization at the time of their initial procedure. There
were 32 patients with unilateral and 8 patients with bilat-
eral 70% to 99% renal artery stenoses, which resulted in an
DISCUSSION
who had bilateral high-grade renal artery stenosis or
the combination of renal artery occlusion and high-
grade renal artery stenosis precludes any definite
conclusions regarding repair of asymptomatic renal
artery stenosis in such patients who require aortic
reconstruction. It is also possible that even longer
follow-up of patients with high-grade renal artery
stenosis may reveal more difficulty with renal insuf-
ficiency. One may argue that prophylactic translumi-
nal angioplasty should still be considered in patients
with asymptomatic renal artery stenosis who require
aortic reconstruction; however, the benign natural
history of ARAS in patients who require aortic
reconstruction argues against any intervention for
renal artery stenosis in such patients. Clearly, renal
artery transluminal angioplasty of renal artery steno-
sis is not without added expense or potential com-
plications. Overall, the data presented here and else-
where do not support “prophylactic” repair of
ARAS by any means in patients who undergo aortic
reconstruction.
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overall prevalence for highgrade renal artery stenosis of
24%. In a mean follow-up period of 6 to 3 years, the
patients with 70% to 99% renal artery lesions showed a
trend toward decreased long-term survival compared with
those with lesser degrees of renal artery disease. Those
patients also had higher systolic blood pressures and
required larger numbers of antihypertensive medications
at the end of the follow-up period. However, there was no
significant change in serum creatinine levels during the
period of observation. The authors concluded that “pro-
phylactic” repair of “asymptomatic” renal artery stenoses
is not justified in patients who require surgical procedures
for abdominal aortic disease.
At the University of Washington, we have an ongoing
prospective study on the natural history of atherosclerotic
renal artery stenosis that relies on serial duplex scanning to
document the status of the renal arteries and kidneys.
Patients are recruited from those screened for renovascular
disease in the vascular laboratory. Our most recent pub-
lished report was on the basis of 76 patients, with 132 eli-
gible renal arteries that were followed for a mean period of
32 months. Progression of renal artery stenosis was rela-
tively common, with an average rate of 7% per year for all
categories of baseline disease combined and a cumulative
incidence of 44% at 2 years for progression from less than
60% to 60% or more stenosis. The risk factors associated
with renal artery disease progression were advanced age,
increased systolic blood pressure, female gender, poor
blood pressure control, and a history of carotid endarterec-
tomy. We also have observed renal atrophy that occurs in
patients with renal artery disease. On the basis of a decrease
in kidney length of 1 cm or more, the cumulative incidence
of renal atrophy at 2 years ranged from 6% for kidneys with
normal renal arteries to 21% for kidneys with 60% or more
renal artery stenoses. The risk factors associated with renal
atrophy were elevated systolic blood pressure, high-grade
renal artery stenosis, and decreased renal cortical blood
flow velocities.
Although we are not ready to make any definitive rec-
ommendations, our natural history data suggest that a sub-
group of patients with renal artery stenoses could benefit
from early renal revascularization. Some of the factors that
appear to be associated with adverse outcomes are high-
grade renal artery stenosis, observed stenosis progression,
renal atrophy, elevated systolic blood pressure, and decreased
blood flow velocities in the renal parenchyma.
As the authors indicate, their patients and the patients
in the University of Washington natural history study are
not directly comparable. Their patients were selected
because they were undergoing surgery for abdominal aor-
tic disease, and our patients were identified through a
screening program for renal artery stenosis. Consequently,
our patients have a higher prevalence of hypertension, and
the proportion of renal arteries with high-grade stenoses
at baseline in our patient population is 46%; it is only 14%
in their study. Our study population was also 47% male,
and theirs was 99% male.
My only question for the authors of this paper con-
cerns the way in which their follow-up data were analyzed
and presented. Although it is stated that the mean follow-
up interval is 6.3 years, no range or standard deviation is
given, so the variability in follow-up among the patients is
unknown. These patients were operated between 1985
and 1990, so it is possible that a few patients were fol-
lowed for long periods and a larger number of patients had
relatively short follow-up intervals. In our natural history
study, the incidence of adverse events, such as end-stage
renal disease, increased with the duration of follow-up.
Therefore, the consistency and length of follow-up is a
critical determinant of the reliability of the data. For the
conclusions to be valid, a representative sample of patients
must be followed for a sufficient period of time. In addi-
tion, the duration of follow-up must be equivalent for all
patient subgroups. A life-table analysis is a more appropri-
ate format for presenting this type of data.
With this in mind, can you tell us how much variabili-
ty there was among the follow-up intervals for individual
patients? Specifically, was the follow-up interval for patients
in each of the renal artery stenosis categories equivalent? I
would be particularly interested in the duration of follow-
up for the patients with unilateral and bilateral high-grade
renal artery stenoses because these are the patients that
should be at the highest risk for ischemic nephropathy.
As a final comment, I would like to propose an alterna-
tive interpretation that leads to a different conclusion
regarding the role of renal revascularization in this patient
population. The authors noted decreased survival, increased
systolic blood pressure, and the need for more antihyper-
tensive medications in patients with high-grade renal artery
stenoses who underwent abdominal aortic surgery, but they
concluded that these findings did not support the need for
concomitant renal artery repair. These observations, along
with data from our own natural history study, indicate that
patients with high-grade renal artery stenoses tend to have
systolic hypertension that is both severe and difficult to treat
pharmacologically. Systolic hypertension has emerged from
numerous epidemiologic studies as one of the most preva-
lent and significant risk factors for cardiovascular disease.
Even a modest degree of systolic hypertension is regarded
as clinically important, and the threshold for defining hyper-
tension has been lowered—the normal level is now less than
130/85 mm Hg. I offer the hypothesis that early renal
revascularization in these patients would enable better
blood pressure control over a long-term period and
increased overall survival. Because death is a more frequent
endpoint than renal failure in our natural history study, this
increase in survival might allow patients to live long enough
to develop ischemic nephropathy. So, do not prematurely
give up the possibility that some of these patients still may
benefit from early renal revascularization.
I compliment the authors on this very interesting and
provocative study, and I appreciate the opportunity for
discussion.
Dr. W. Kent Williamson. Thank you, Dr. Zierler, for
your insightful comments. I would like to address these in
order.
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First, your question on variability and the follow-up in
our study is an excellent point. The question actually
brings up a fault and probably the shortcomings of a ret-
rospective analysis primarily.
As I mentioned in the discussion, the follow-up years
ranged from 1.1 to 10.6 years overall. I do not have spe-
cific data with regards to follow-up within each of the cat-
egories that I have outlined—groups A through D.
The best way to address this problem would be to
increase the numbers in our study. We hoped that using
171 patients would help us attack that. However, it is
obviously not perfect. The best way to address the prob-
lem may be to perform a prospective analysis overall.
With regard to your comments about the conclusion
in the study, the bottom line or the hard end point of our
study was, again, the need for dialysis. As I mentioned,
only one patient or 0.6% of the study population became
dialysis dependent, and that patient had minimal renal
artery stenosis when first seen.
Some other issues needed to be discussed. You men-
tioned difficulty in controlling blood pressure, and that is
also a matter of interpretation of the data. In my mind, an
increased systolic blood pressure from around 137 mm
Hg to a mean of 154 mm Hg may not necessarily repre-
sent a poorly controlled blood pressure. Again, though,
that is a mean, and it does represent some high variability.
Also, the increased numbers of antihypertensive med-
ications that were used may not have been clinically sig-
nificant but were statistically significant. The overall num-
ber or mean number of antihypertensive medication used
in group D, the 70% to 99% stenosis group at last follow-
up, was around 1.5 to 1.7 antihypertensive medications.
So, at the time of initial aortic repair, is it really worth
subjecting a patient to increased morbidity and mortality
rates—which have been quoted as high as 31%—to save an
extra antihypertensive medication?
Dr. Fred Weaver (Los Angeles, Calif.). This is a good
paper, and the topic is important, particularly with the
endoluminal grafting and the presence of concomitant
renal artery stenosis.
Because the patient group that develops ischemic
nephropathy usually has bilateral renal artery disease, did
you look at and separate 10 patients who had a unilateral
severe stenosis versus those patients who had a unilateral
high-grade stenosis and contralateral renal artery disease
greater than 50 percent? Did you analyze your data with
regards to serum creatinine and hypertension?
Dr. Williamson. You make an excellent point. In fact,
we did attempt to separate the groups on the basis of
whether they had unilateral or bilateral 70% to 99% steno-
sis. We found the sample size, only 8 patients had bilater-
al 70% to 99% stenosis, was not enough to achieve statis-
tical significance or power.
Therefore, we cannot make any reliable conclusions
regarding the natural history of patients with bilateral
greater than 70% to 99% stenosis.
Dr. Ron Stoney (San Francisco, Calif.). I enjoyed your
paper, Dr. Williamson. I think the Oregon group is look-
ing carefully at whether or not prophylactic renal artery
repair is justified.
At the University of California at San Francisco, we have
had a prophylactic group in each series of operations on the
juxta- or pararenal aorta that we have reported. We saw no
increase in morbidity rate in this group, compared with
symptomatic patients, and yet, it is recognized that com-
bined aortorenal reconstructions do increase risk for aortic
reconstructions alone. Therefore, it is good to be selective.
I have one comment, which is similar to Dr. Zierler’s
comment. Some of these patients actually should be consid-
ered hypertensive and not asymptomatic on the basis of
reported blood pressure elevations and the use of antihyper-
tensive medications. Perhaps this could be woven into your
reinterpretation of symptomatic and asymptomatic patients.
My other concern involves follow-up. In this population
of patients, were you able to look at the angiographic status
of disease in any patients over the time period that they were
followed? Papers by Dr. Richard Dean and Dr. Calvin Ernst
both describe progression of renal artery disease by imaging
studies. If the disease does not progress, then how does
symptomatic renal artery stenosis develop in patients?
Dr. Williamson. Both of your points are excellent. To
address the first point about whether or not these patients
are truly asymptomatic, the key feature of this study is that
these patients were not identified with renal vascular dis-
ease or hypertension. In fact, at the time first seen, the
patients with 70% to 99% stenosis did have higher systolic
blood pressure and hypertension, but they were not felt to
have indications for renal artery revascularization.
Other investigators have suggested that perhaps patients
who are deemed asymptomatic are really symptomatic when
they are placed under higher scrutiny. Does that necessarily
mandate a revascularization at the time of surgery? We sug-
gest that if it is that difficult to tell they have symptomatic
renal vascular disease, then the increased risk of renal revas-
cularization at the time of aortic resection is not justified.
With regard to your second question, we did not
obtain or review follow-up aortograms. Dr. Towlson and
Dr. Ernst are two investigators who have done a series of
about 70 patients where follow-up aortograms were
obtained for other reasons and then reviewed for progres-
sion of renal artery stenosis.
Those particular patient groups may not necessarily
compare with our patient group because those patients are
selected on the basis of the need for repeat aortography
and, hence, may be a “sicker” group of patients.
We wanted to focus on the functional and clinical out-
come rather than the anatomic outcome, which we think
is actually the more important endpoint.
